Cargando…

Utility of [18F]-fluoroestradiol (FES) PET/CT with dedicated brain acquisition in differentiating brain metastases from posttreatment change in estrogen receptor-positive breast cancer

Detalles Bibliográficos
Autores principales: Ivanidze, Jana, Subramanian, Kritika, Youn, Trisha, Cigler, Tessa, Osborne, Joseph R, Magge, Rajiv S, Balogun, Onyinye D, Knisely, Jonathan P S, Ramakrishna, Rohan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8713741/
https://www.ncbi.nlm.nih.gov/pubmed/34988456
http://dx.doi.org/10.1093/noajnl/vdab178
_version_ 1784623804328181760
author Ivanidze, Jana
Subramanian, Kritika
Youn, Trisha
Cigler, Tessa
Osborne, Joseph R
Magge, Rajiv S
Balogun, Onyinye D
Knisely, Jonathan P S
Ramakrishna, Rohan
author_facet Ivanidze, Jana
Subramanian, Kritika
Youn, Trisha
Cigler, Tessa
Osborne, Joseph R
Magge, Rajiv S
Balogun, Onyinye D
Knisely, Jonathan P S
Ramakrishna, Rohan
author_sort Ivanidze, Jana
collection PubMed
description
format Online
Article
Text
id pubmed-8713741
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-87137412022-01-04 Utility of [18F]-fluoroestradiol (FES) PET/CT with dedicated brain acquisition in differentiating brain metastases from posttreatment change in estrogen receptor-positive breast cancer Ivanidze, Jana Subramanian, Kritika Youn, Trisha Cigler, Tessa Osborne, Joseph R Magge, Rajiv S Balogun, Onyinye D Knisely, Jonathan P S Ramakrishna, Rohan Neurooncol Adv Molecular Tumor Board Case Report Oxford University Press 2021-11-30 /pmc/articles/PMC8713741/ /pubmed/34988456 http://dx.doi.org/10.1093/noajnl/vdab178 Text en © The Author(s) 2021. Published by Oxford University Press, the Society for Neuro-Oncology and the European Association of Neuro-Oncology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Molecular Tumor Board Case Report
Ivanidze, Jana
Subramanian, Kritika
Youn, Trisha
Cigler, Tessa
Osborne, Joseph R
Magge, Rajiv S
Balogun, Onyinye D
Knisely, Jonathan P S
Ramakrishna, Rohan
Utility of [18F]-fluoroestradiol (FES) PET/CT with dedicated brain acquisition in differentiating brain metastases from posttreatment change in estrogen receptor-positive breast cancer
title Utility of [18F]-fluoroestradiol (FES) PET/CT with dedicated brain acquisition in differentiating brain metastases from posttreatment change in estrogen receptor-positive breast cancer
title_full Utility of [18F]-fluoroestradiol (FES) PET/CT with dedicated brain acquisition in differentiating brain metastases from posttreatment change in estrogen receptor-positive breast cancer
title_fullStr Utility of [18F]-fluoroestradiol (FES) PET/CT with dedicated brain acquisition in differentiating brain metastases from posttreatment change in estrogen receptor-positive breast cancer
title_full_unstemmed Utility of [18F]-fluoroestradiol (FES) PET/CT with dedicated brain acquisition in differentiating brain metastases from posttreatment change in estrogen receptor-positive breast cancer
title_short Utility of [18F]-fluoroestradiol (FES) PET/CT with dedicated brain acquisition in differentiating brain metastases from posttreatment change in estrogen receptor-positive breast cancer
title_sort utility of [18f]-fluoroestradiol (fes) pet/ct with dedicated brain acquisition in differentiating brain metastases from posttreatment change in estrogen receptor-positive breast cancer
topic Molecular Tumor Board Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8713741/
https://www.ncbi.nlm.nih.gov/pubmed/34988456
http://dx.doi.org/10.1093/noajnl/vdab178
work_keys_str_mv AT ivanidzejana utilityof18ffluoroestradiolfespetctwithdedicatedbrainacquisitionindifferentiatingbrainmetastasesfromposttreatmentchangeinestrogenreceptorpositivebreastcancer
AT subramaniankritika utilityof18ffluoroestradiolfespetctwithdedicatedbrainacquisitionindifferentiatingbrainmetastasesfromposttreatmentchangeinestrogenreceptorpositivebreastcancer
AT yountrisha utilityof18ffluoroestradiolfespetctwithdedicatedbrainacquisitionindifferentiatingbrainmetastasesfromposttreatmentchangeinestrogenreceptorpositivebreastcancer
AT ciglertessa utilityof18ffluoroestradiolfespetctwithdedicatedbrainacquisitionindifferentiatingbrainmetastasesfromposttreatmentchangeinestrogenreceptorpositivebreastcancer
AT osbornejosephr utilityof18ffluoroestradiolfespetctwithdedicatedbrainacquisitionindifferentiatingbrainmetastasesfromposttreatmentchangeinestrogenreceptorpositivebreastcancer
AT maggerajivs utilityof18ffluoroestradiolfespetctwithdedicatedbrainacquisitionindifferentiatingbrainmetastasesfromposttreatmentchangeinestrogenreceptorpositivebreastcancer
AT balogunonyinyed utilityof18ffluoroestradiolfespetctwithdedicatedbrainacquisitionindifferentiatingbrainmetastasesfromposttreatmentchangeinestrogenreceptorpositivebreastcancer
AT kniselyjonathanps utilityof18ffluoroestradiolfespetctwithdedicatedbrainacquisitionindifferentiatingbrainmetastasesfromposttreatmentchangeinestrogenreceptorpositivebreastcancer
AT ramakrishnarohan utilityof18ffluoroestradiolfespetctwithdedicatedbrainacquisitionindifferentiatingbrainmetastasesfromposttreatmentchangeinestrogenreceptorpositivebreastcancer